---
$id: https://graph.org.ai/products/commodity/51281621
$type: Product
source: UNSPSC
code: "51281621"
title: "Propikacin"
class: "51281600"
classTitle: "Aminoglycosides"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Propikacin

**UNSPSC Code**: 51281621
**Class**: [Aminoglycosides](Aminoglycosides.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an aminoglycoside antibiotic with the molecular formula C21H43N5O12, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9X6F5H479X, chemically known as uk 31,214 but generally known as propikacin, which bears US NIH Compound Identifier 68557. European Medicines Agency schedules Propikacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10107MIG. The term PROPIKACIN is an International Non-Proprietary Name. PROPIKACIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule propikacin under HS 29419000 and SITC 54139. As of Q4 2014, PROPIKACIN remains the US FDA Preferred Term for this commodity. Propikacin bears US NLM identifiers UMLS ID C0610191 and NCI Concept Code C75063. SMILES: O(C1C(NC(CO)CO)CC(N)C(OC2OC(C(O)C(O)C2N)CN)C1O)C1OC(C(O)C(N)C1O)CO.

